Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Theophylline monohydrate |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline calcium salicylate |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline measurement, saliva |
Component |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Theophylline measurement, blood |
Component |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Accidental theophylline poisoning |
Causative agent (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional theophylline poisoning |
Causative agent (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la théophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline adverse reaction (disorder) |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to theophylline |
Causative agent (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline overdose (disorder) |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental theophylline overdose |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional theophylline overdose |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de théophylline d'intention indéterminée |
Causative agent (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline monohydrate (as theophylline sodium glycinate) 12 milligram/1 milliliter conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 175mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 250mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 125mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 250mg m/r capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 300mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 400 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 80mg/15mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 450mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline, anhydrous 300mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline, anhydrous 80mg/15mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + theophylline 100mg/150mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + theophylline 100mg/80mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + theophylline 200mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + theophylline 90mg/150mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin + theophylline, anhydrous 90mg/150mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium iodide + theophylline, anhydrous 130mg/80mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline, anhydrous 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline, anhydrous 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline sodium glycinate |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choline theophyllinate (substance) |
Is a |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum theophylline level (procedure) |
Component |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Poisoning by theophylline |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ephedrine sulfate and hydroxyzine hydrochloride and theophylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma theophylline level (procedure) |
Component |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 65mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 130mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline 260mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental theophylline poisoning |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional theophylline poisoning |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mersalyl sodium+theophylline 100mg/50mg/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing theophylline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of theophylline trough concentration |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of theophylline peak concentration (procedure) |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline measurement |
Component |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to theophylline |
Causative agent (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 125 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Theophylline 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |